Do GLP-1 receptor agonists increase the risk of suicide in patients?

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal behaviors in high-risk populations.

Anumana names Boston Scientific veteran Maulik Nanavaty as CEO

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Name: Maulik Nanavaty New title: CEO, Anumana

October 20, 2023

Reversing Anticoagulation in Hemorrhagic Stroke; E-Cigs for Smoking Cessation

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

February 18, 2024

Q&A: Lilly science chief Dan Skovronsky talks dealmaking, AI and consistent investing

Eli Lilly is on a hot streak. It’s about to find out whether its diabetes drug can also be marketed for weight management. Its Alzheimer’s

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.